Par Pharm Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PAR PHARM INC, and what generic alternatives to PAR PHARM INC drugs are available?
PAR PHARM INC has twelve approved drugs.
There is one US patent protecting PAR PHARM INC drugs. There are seven tentative approvals on PAR PHARM INC drugs.
There are nine patent family members on PAR PHARM INC drugs in eight countries and twenty-three supplementary protection certificates in thirteen countries.
Summary for Par Pharm Inc
| International Patents: | 9 |
| US Patents: | 1 |
| Tradenames: | 11 |
| Ingredients: | 11 |
| NDAs: | 12 |
Drugs and US Patents for Par Pharm Inc
International Patents for Par Pharm Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2605413 | ⤷ Sign Up |
| Japan | 5378788 | ⤷ Sign Up |
| European Patent Office | 1948613 | ⤷ Sign Up |
| Japan | 2008538560 | ⤷ Sign Up |
| Australia | 2006240490 | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2006115626 | ⤷ Sign Up |
| Mexico | 2007013118 | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Par Pharm Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0237929 | 97C0112 | Belgium | ⤷ Sign Up | PRODUCT NAME: TOLCAPONE; REGISTRATION NO/DATE: EU/1/97/044/001 19970827 |
| 2330892 | 122016000107 | Germany | ⤷ Sign Up | PRODUCT NAME: GLYCEROLPHENYLBUTYRAT; REGISTRATION NO/DATE: EU/1/15/1062 20151127 |
| 2101777 | 2016C/032 | Belgium | ⤷ Sign Up | PRODUCT NAME: AMBRISENTAN EN COMBINAISON AVEC LE TADALAFIL; AUTHORISATION NUMBER AND DATE: EU/1/08/451 20151125 |
| 2101777 | PA2016018 | Lithuania | ⤷ Sign Up | PRODUCT NAME: AMBRISENTANAS; REGISTRATION NO/DATE: EU/1/08/451 (001-004) 20151120 |
| 0785926 | SPC/GB08/047 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: AMBRISENTAN; REGISTERED: UK EU/1/08/451/001 20080421; UK EU/1/08/451/002 20080421; UK EU/1/08/451/003 20080421; UK EU/1/08/451/004 20080421 |
| 2330892 | 93351 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: GLYCEROL PHENYLBUTYRATE; AUTHORISATION NUMBER AND DATE: EU/1/15/1062 |
| 2101777 | 300813 | Netherlands | ⤷ Sign Up | PRODUCT NAME: AMBRISENTAN TOEGEPAST IN COMBINATIEBEHANDELING MET TADALAFIL; REGISTRATION NO/DATE: EU/1/08/451 (C(2008) 1637) 20151125 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
